Viking Therapeutics could reach a whole new market with its weight-loss pill: analyst
Jay Olson, managing director and senior biotechnology research analyst at Oppenheimer, joins BNN Bloomberg to discuss Viking Therapeutics as it rises today on weight-loss drug testing.
